Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Government details B. canis risk to Great Britain
The likelihood of an infected dog arriving in Great Britain varied by country.

Assessment reveals ‘high’ likelihood infected dogs will enter country.

The UK government has released a qualitative risk assessment of the likelihood of Brucella canis (B. canis) entering Great Britain.

Its analysis examined how the global movement of dogs could lead to dogs and foxes in the country becoming infected with brucellosis.

The risk assessment concluded that there was high annual likelihood of at least one infected dog entering Great Britain from many other countries. However this likelihood varied depending on the country of origin.

For example the likelihood of an infected dog travelling in from New Zealand and Australia, either by commercial route or on a short visit, was deemed to be very low.

From all other countries, however, the risk of an infected dog entering Great Britain through a commercial route was considered high. Similarly, the government assessed that all countries outside of Western Europe, except New Zealand and Australia, had a medium risk of allowing an infected dog to travel to Great Britain for a short visit.

Where B. canis did enter Great Britain, the government believes the likelihood of further cases to be high for breeding animals and low for all other dogs. However, the transmission risk to a naive dog in Great Britain was assessed to be high if they are the offspring of an infected dog, and medium for the breeding mates of an infected dog.

The government says that there remains a high degree of uncertainty throughout the risk assessment due to a lack of reliable data.

Evidence gaps included limited understanding of B. canis prevalence in other individual countries, infected dogs’ country of origin, and the frequency of which native dogs would mate with infected dogs. There was also uncertainty about transmission between wildlife and domestic dogs.

The full risk assessment can be viewed here.

Image used under license from Shutterstock, Inc.

Copyright (C) Chris worldwide/Shutterstock.com

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
BSAVA announces 12th Edition of the Small Animal Formulary

The BSAVA has published an updated edition of its Small Animal Formulary, which includes new drug monographs and emergency drug doses for rabbits, rodents, birds and reptiles.

One of BSAVA's most trusted and widely used clinical resources, this 12th edition of the manual also includes seven new client information leaflets and information on drugs used for the management of urinary incontinence.

Part A of the Formulary, Canine and Feline, sees Fergus Allerton return as Editor-in-Chief, while Part B: Exotic Pets was edited by Joanna Hedley. For more information, visit the BSAVA website.